Addex Therapeutics
(NASDAQ) ADXN
Addex Therapeutics Financials at a Glance
Market Cap
$7.59M
Revenue (TTM)
$67.61K
Net Income (TTM)
$6.10M
EPS (TTM)
$-8.43
P/E Ratio
-0.72
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$6.14
Volume
85
Open
$6.15
Price
$6.14
Volume
85
Open
$6.15
Previous Close
$6.14
Daily Range
$6.14 - $6.15
52-Week Range
$5.57 - $12.05
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$6.14
Volume
85
Open
$6.15
Previous Close
$6.14
Daily Range
$6.14 - $6.15
52-Week Range
$5.57 - $12.05
ADXN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Addex Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Tim Dyer
Website
www.addextherapeutics.comHeadquarters
Geneva, 1202, CH
ADXN Financials
Key Financial Metrics (TTM)
Gross Margin
-14%
Operating Margin
-18%
Net Income Margin
-44%
Return on Equity
-71%
Return on Capital
-40%
Return on Assets
-83%
Earnings Yield
-1.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.59M
Shares Outstanding
1.26M
Volume
85
Short Interest
0.00%
Avg. Volume
5.36K
Financials (TTM)
Gross Profit
$404.10K
Operating Income
$2.76M
EBITDA
$4.65M
Operating Cash Flow
$5.37M
Capital Expenditure
$1.27K
Free Cash Flow
$5.37M
Cash & ST Invst.
$3.35M
Total Debt
$41.99K
Addex Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$29.72K
-44.8%
Gross Profit
$29.72K
-44.8%
Gross Margin
100.00%
N/A
Market Cap
$7.59M
N/A
Market Cap/Employee
$3.80M
N/A
Employees
2
N/A
Net Income
$1.58M
-3.1%
EBITDA
$1.57M
-6.9%
Quarterly Fundamentals
Net Cash
$2.16M
-34.8%
Accounts Receivable
$51.25K
-90.1%
Inventory
$0.00
N/A
Long Term Debt
$28.96K
-20.8%
Short Term Debt
$7.58K
+5.1%
Return on Assets
-83.17%
N/A
Return on Invested Capital
-40.30%
N/A
Free Cash Flow
$533.20K
-33.3%
Operating Cash Flow
$533.20K
-33.8%